Clinical Trial Update: A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

View source ↗

Summary

A clinical trial evaluating Lumigan (bimatoprost) in patients with open-angle glaucoma or ocular hypertension has completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Lumigan (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Status: COMPLETED | Results posted: 2012-09-21